Procter & Gamble Health on Thursday said its profit after tax declined 21% year-on-year to Rs 46 crore for the third quarter ended March 2024.
The company, which follows the July-June financial year, reported a profit after tax of Rs 59 core a year ago.
Its revenue from operations declined to Rs 252 crore for the period under review compared to Rs 321 crore in the year-ago period, Procter & Gamble Health said in a regulatory filing.
"The company's continued efforts to strengthen our reach and distribution with a transformed go-to-market model reflected in a one-time impact on the quarter's sales owing to the transition and optimisation of trade management and inventory," P&G Health India Managing Director Milind Thatte said.
"However, we have seen sales recover in the months of March and April," he added.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
